Navigation Links
TPI Ships Macrolide API Samples for International Sales Standard Testing
Date:7/22/2011

CHENGDU, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the research, development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients (API) today announced that the Company has shipped the first batch of Azithromycin API sample to RELATIONS International Ltd. for Bangladesh export standard test.  

This is the first step for the development of macrolide international export business for TPI following the signing of the sales and marketing agreement with RELATIONS International Ltd., a Bangladesh corporation that specializes in API product sales in the People's Republic of Bangladesh, in June this year.

Jiangchuan Macrolide facility (JCM) currently has an active production license for manufacturing Azithromycin API (H10970072). Additional information regarding JCM can be found at www.sfda.gov.cn (Chinese version).  

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and active pharmaceutical ingredients (API). TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
2. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
3. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
4. Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
5. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
6. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
7. AMD LASERS Announces Partnerships With Three Industry-Leading Companies
8. PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
9. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
10. Codexis Expands Pharmaceutical Manufacturing Partnerships
11. ExpertRECALL Awards First Scholarships for Product-Safety Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Pharmaceuticals, a,private biotechnology company discovering and developing ... a proof-of-concept clinical trial of,SLC022 in patients ... of shingles, affects approximately 200,000 people a ... is an international, multi-center,placebo-controlled study that will ...
... InterMune, Inc.,(Nasdaq: ITMN ) today announced that ... January 12 at 8:30 a.m. EST to discuss results ... (HCV) protease inhibitor ITMN-191,(R7227) in combination with Pegasys(R) (interferon ... genotype 1. ITMN-191 is,being developed in collaboration with Roche. ...
Cached Medicine Technology:Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia 2InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191 2
(Date:4/17/2014)... Scientists have identified the first genetic variant specifically ... sub-type accounting for around 10-15 per cent of ... study of the breast cancer sub-type, called invasive ... genetic causes of this particular kind of breast ... The research, published today (Thursday) in the journal ...
(Date:4/17/2014)... University of California, San Diego School of Medicine report ... suffered a recent major loss are more likely to ... The study is published in this month,s issue of ... Because compassionate behaviors are associated with better health and ... into ways to improve the outcomes of individuals whose ...
(Date:4/17/2014)... New Rochelle, NY, April 17, 2014U.S. military personnel ... "blast plus impact" concussive traumatic brain injury (TBI) ... were evacuated for other medical reasons. Differences in ... and depression 6-12 months after injury are reported ... , a peer-reviewed journal from Mary Ann Liebert, ...
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
(Date:4/17/2014)... A. Arias, M.D., Ph.D., at The University of Texas ... new superbug that caused a bloodstream infection in a ... issue of The New England Journal of Medicine ... class of highly-resistant bacteria known as methicillin-resistant Staphylococcus ... of hospital and community-associated infections. The superbug has also ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2
... of vegetables in childhood lower risk// of stroke.This link ... a very interesting study published in the journal Heart. ... not just due to exposure to risk factors in ... an entire lifetime. Previous studies have suggested that diets ...
... with the help of anti fungal medication itraconazole can ... Manchester have broken new grounds in asthma treatment by ... bronchopulmonary aspergillosis, which is a form of asthma. , ... treated with steroids or drugs that have equally disastrous ...
... the use of strontium ranelate to be used for treating ... drug it is important to observe the changes in the ... Journal has said that the drug strontium ranelate have an ... effect can be used in advantage of the treatment procedure. ...
... researchers at Massachusetts General Hospital// and the Harvard School of ... may lower the risk of type II diabetes in men. ... produce enough insulin or the cells ignore the insulin. Insulin ... sugar. Type II diabetes typically occurs in individuals older than ...
... stomach infections caused by Helicobacter pylori might be ... pylori are common bacteria that reside in the ... infections. Previous research had connected the bacteria with ... ischemic heart disease. ,Researchers have tested patients ...
... common genetical variants that increase the risk for developing// ... condition in which kidneys of the body are unable ... waste balance that is part of the metabolism practice. ... that can lead to toxicity of the body. Chronic ...
Cached Medicine News:Health News:Association between childhood diet and stroke 2
... opening to block tear drainage through the ... dry eye symptoms, and enable the eye ... tears:, Low-profile cap design virtually eliminates ... facilitates easy removal with jewelers forceps, if ...
Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
Medicine Products: